• Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research

  • Apr 25 2024
  • Durata: 47 min
  • Podcast
Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research copertina

Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research

Ascolta gratuitamente

Vedi i dettagli del titolo

  • Riassunto

  • In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.

    • Antonio Ciaccia, President, 3 Axis Advisors and CEO, 46brooklyn Research, an Ohio non-profit Corporation
    • 46brooklyn
    • Ohio Pharmacist Association
    • 3 Axis Advisors
    • Medicaid
    • 340B Program
    • 340B Litigation
    • 340 Eligibility, HRSA
    • Covered Entities
    • Medicaid Drug Rebate Program
    • Obamacare
    • Indian Health Service
    • "Money from Sick People," Report from 46Brooklyn
    • Medicare
    • Pharmacy Benefit Managers (PBMs)
    • Jamie Robinson, Health Economist

    Medical terminology referenced in this episode:

    • Novolog

    Questions or comments?
    Email us at comments@prescriptionforbetteraccess.com.
    Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
    Mostra di più Mostra meno

Sintesi dell'editore

In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.

  • Antonio Ciaccia, President, 3 Axis Advisors and CEO, 46brooklyn Research, an Ohio non-profit Corporation
  • 46brooklyn
  • Ohio Pharmacist Association
  • 3 Axis Advisors
  • Medicaid
  • 340B Program
  • 340B Litigation
  • 340 Eligibility, HRSA
  • Covered Entities
  • Medicaid Drug Rebate Program
  • Obamacare
  • Indian Health Service
  • "Money from Sick People," Report from 46Brooklyn
  • Medicare
  • Pharmacy Benefit Managers (PBMs)
  • Jamie Robinson, Health Economist

Medical terminology referenced in this episode:

  • Novolog

Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
Disturbo fisico e malattia Igiene e vita sana Scienze biologiche
Mostra di più Mostra meno

Cosa pensano gli ascoltatori di Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research

Valutazione media degli utenti. Nota: solo i clienti che hanno ascoltato il titolo possono lasciare una recensione

Recensioni - seleziona qui sotto per cambiare la provenienza delle recensioni.

Recensioni da Audible.it

Recensioni da Amazon
Non ci sono recensioni disponibili